Editas Medicine Inc - Company Profile
Powered by 
All the sales intelligence you need on Editas Medicine Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Editas Medicine Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Editas Medicine Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Editas Medicine Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Editas Medicine Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Jessica Hopfield, Ph.D.
Chairman Executive BoardMs. Jessica Hopfield has been the Chairwoman of the company since December 2024. Prior to this, she served as the Directors of Insulet Corporation and Maravai LifeSciences Holdings Inc. Previously, she served as the Director of Radius Health Inc and PhenomeX Inc. Ms. Hopfield also served as a Partner of McKinsey & Company in its global pharmaceuticals and medical devices practice.
Gilmore O’Neill
President; Chief Executive Officer; Director Executive BoardMr. Gilmore O’Neill has been the President, Director, and Chief Executive Officer of the company since June 2022. Prior to this, he served as the Executive Vice President of R&D and Chief Medical Officer of Sarepta Therapeutics from 2018 to 2022. Previously, he served as the Senior Vice President of Biogen. Mr. O’Neill also served as the Board of Directors at Unity Biotechnology Inc.
Amy Parison
Chief Financial Officer; Senior Vice President Senior ManagementMs. Amy Parison has been the Chief Financial Officer and Senior Vice President of the company since March 2025. Prior to this, she served as the Vice President of Finance of the company. Previously, she served as the Corporate Controller of Rubius Therapeutics. Ms. Parison also worked at Vertex Pharmaceuticals and PricewaterhouseCoopers, LLP.
Linea Aspesi
Executive Vice President; Chief Administrative Officer Senior ManagementMs. Linea Aspesi has been the Executive Vice President and Chief Administrative Officer of the company since March 2025. Prior to this, she served as the Chief People Officer of the company. Previously, she served as the Chief Human Resources Officer of Forma Therapeutics and Saniona; and Vice President and Head of Human Resources for North America Region at Sobi Inc. Ms. Aspesi also served as the Associate Vice President and Head of Human Resources at Sanofi Genzyme.
Linda C. Burkly, Ph.D.
Chief Scientific Officer\Senior Management Senior ManagementMs. Linda C. Burkly has been the Chief Scientific Officer and Executive Vice President of the company since 2023. Prior to this, she served as the Vice President and Senior Distinguished Investigator at Biogen. Ms. Burkly also served as the Head of Acute Neurology Research. Earlier, she served as Vice president and Senior Distinguished Investigator in Immunology.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer